Group structure
7 companies in 4 countries
Loading…
7 companies in 4 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
16 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| APTIOM200mg | 400mg | 600mg | 800mg · Tablet | Eslicarbazepine | United States | Marketed | 2013 |
| GEMTESA75mg · Tablet | Vibegron | United States | Marketed | 2020 |
| KYNMOBI10mg | 15mg | 20mg | 25mg | 30mg · Film | Apomorphine | United States | Not marketed | 2020 |
| LONHALA MAGNAIR KIT25mcg/ml · Solution | Glycopyrronium | United States | Not marketed | 2017 |
| MYFEMBREE1mg; 0.5mg; 40mg · Tablet | Estradiol, Norethindrone, Relugolix | United States | Marketed | 2021 |
| ORGOVYX120mg · Tablet | Relugolix | United States | Marketed | 2020 |
| RethymicSemi-quantitative · For Suspension | Allogeneic processed thymus tissue | United States | Marketed | 2021 |
| APTIOM200 mg · Tablet | Eslicarbazepine | Canada | Cancelled | 2014 |
| APTIOM400 mg · Tablet | Eslicarbazepine | Canada | Cancelled | 2014 |
| APTIOM800 mg · Tablet | Eslicarbazepine | Canada | Cancelled | 2014 |
| APTIOM600 mg · Tablet | Eslicarbazepine | Canada | Cancelled | 2014 |
| LATUDA80 mg · Tablet | Lurasidone | Canada | Cancelled | 2012 |
| LATUDA40 mg · Tablet | Lurasidone | Canada | Cancelled | 2012 |
| LATUDA20 mg · Tablet | Lurasidone | Canada | Cancelled | 2014 |
| LATUDA60 mg · Tablet | Lurasidone | Canada | Cancelled | 2014 |
| LATUDA120 mg · Tablet | Lurasidone | Canada | Cancelled | 2012 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 9 | 0 | 9 | CompaniesAll medicines |
| United States | 7 | 7 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Keep Sumitomo’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.